Anika Therapeutics, Inc. (ANIK)
14.75
-0.05
(-0.34%)
USD |
NASDAQ |
Apr 06, 16:00
14.74
-0.01
(-0.07%)
After-Hours: 20:00
Anika Therapeutics SG&A Expense (TTM) : 49.09M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| BioCryst Pharmaceuticals, Inc. | 348.65M |
| Lantheus Holdings, Inc. | 453.81M |
| TELA Bio, Inc. | 78.88M |
| Plus Therapeutics, Inc. | 12.13M |
| BioStem Technologies, Inc. | 116.97M |